Vascular Patency

• 

  Subject Areas on Research

  • A comparative study of the effect of arterial and venous occlusion after various periods of ischemia. 
  • A comparison between the HeRO graft and conventional arteriovenous grafts in hemodialysis patients. 
  • A hybrid approach using a composite endovascular and open graft procedure for a symptomatic common femoral aneurysm extending well above the inguinal ligament. 
  • A large-scale study of the upper arm basilic transposition for hemodialysis. 
  • A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. 
  • A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. 
  • A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1. 
  • A systematic review of venous stents for iliac and venacaval occlusive disease. 
  • A technique for improved blood sampling during sleep studies. 
  • Abciximab readministration: results of the ReoPro Readministration Registry. 
  • Acute Limb Ischemia. 
  • Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators. 
  • Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. 
  • An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study Group. 
  • An expanded series of distal bypass using the distal vein patch technique to improve prosthetic graft performance in critical limb ischemia. 
  • An overview of laparoscopic techniques in abdominal aortic aneurysm repair. 
  • Angiographic changes in vein grafts: stable surrogate or seductive siren? 
  • Antithrombotic potencies of enoxaparin in microvascular surgery: influence of dose and administration methods on patency rate of crushed arterial anastomoses. 
  • Are narrower or wider retinal venules associated with incident hypertension? 
  • Arterial reconstruction in the ischemic hand and wrist: effects on microvascular physiology and health-related quality of life. 
  • Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease. 
  • Arterial reconstructions for chronic lower extremity ischemia in preadolescent and adolescent children. 
  • Arterial stump pressure: a determinant of arterial patency? 
  • Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes. 
  • Arteriovenous Graft Delamination and Dissection as a Cause of Graft Dysfunction. 
  • Arteriovenous Graft Failure in the Veterans Health Administration: Outcome Disparities Associated with Race. 
  • Assessing flow during minimally invasive coronary artery bypass: an Allen's test equivalent. 
  • Assessing the patency of mediastinal and thoracic inlet veins: value of MR imaging. 
  • Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7. 
  • Assessment of vascular contrast and depiction of stenoses in abdominopelvic and lower extremity vasculature: comparison of dual-energy MDCT with digital subtraction angiography. 
  • Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. 
  • Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis. 
  • Bioengineered hemodialysis access grafts. 
  • Body fat distribution, metabolic and inflammatory markers and retinal microvasculature in school-age children. The Generation R Study. 
  • Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease. 
  • Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial. 
  • Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014. 
  • Clinical and angiographic assessment of complex mammary artery bypass grafting. 
  • Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial. 
  • Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. 
  • Closed plication is a safe and effective method for treating popliteal vein aneurysm. 
  • Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. 
  • Comparing off-pump and on-pump clinical outcomes and costs for diabetic cardiac surgery patients. 
  • Comparison of 10-0 polypropylene and 10-0 nylon sutures in rat arterial anastomosis. 
  • Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study Group. 
  • Comparison of continuous and interrupted suture techniques in microvascular anastomosis. 
  • Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. 
  • Contemporary outcomes after distal vertebral reconstruction. 
  • Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. 
  • Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. 
  • Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group. 
  • Coronary stent patency: dual-energy multidetector CT assessment in a pilot study with anthropomorphic phantom. 
  • Correction of central venous stenoses: use of angioplasty and vascular Wallstents. 
  • Costoclavicular venous decompression in patients with threatened arteriovenous hemodialysis access. 
  • Creation of an Extraluminal Arterial Bypass Graft Using a Commercially Available Self-Expanding Stent Graft: Feasibility Study in a Porcine Model. 
  • Decreased thrombogenicity of vascular prostheses following gas denucleation by hydrostatic pressure. 
  • Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial. 
  • Duplex ultrasound scanning versus computed tomographic angiography for postoperative evaluation of endovascular abdominal aortic aneurysm repair. 
  • Early and late outcome following deployment of a new flexible tantalum intracoronary stent in dogs. 
  • Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump. 
  • Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. 
  • Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. 
  • Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. 
  • Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries. 
  • Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. 
  • Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. 
  • Endovascular therapy: is it effective in the diabetic limb? 
  • Endovascular treatment of femoro-popliteal lesions. 
  • Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial. 
  • Evaluation of a polyepoxy compound fixed biological vascular prosthesis and an expanded polytetrafluoroethylene vascular graft. 
  • Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group. 
  • Evolution of an automated ST-segment analysis program for dynamic real-time, noninvasive detection of coronary occlusion and reperfusion. 
  • Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction. 
  • External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial. 
  • Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. 
  • Fistula dysfunction: effect on rapid hemodialysis. 
  • Forearm versus upper arm grafts for vascular access. 
  • Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia. 
  • Guideline adjudicated fibrinolytic failure: incidence, findings, and management in a contemporary clinical trial. 
  • Hemodialysis Reliable Outflow device impingement in the subclavian position: a case report. 
  • Hemodialysis vascular access: effect on urea kinetics and the dialysis prescription. 
  • Hemodynamic and histological differences in end-to-side anastomoses. 
  • Heparin bonding increases patency of long microvascular prostheses. 
  • How paclitaxel can improve results in diabetics. 
  • Hybrid procedures in the treatment of thoracoabdominal aortic aneurysms: a systematic review. 
  • Hypercoagulability affecting early vein graft patency does not exist after off-pump coronary artery bypass. 
  • Impact of anticoagulation/antiplatelet therapy on femoropopliteal bypass graft outcomes. 
  • Impact of infarct artery patency on the relationship between electrocardiographic and ventriculographic evidence of acute myocardial ischaemia. 
  • Impact of lipid-lowering medications and low-density lipoprotein levels on 1-year clinical outcomes after coronary artery bypass grafting. 
  • Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters. 
  • Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group. 
  • Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group. 
  • Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction. 
  • Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients. 
  • Improved microsurgical anastomotic patency with low molecular weight heparin. 
  • Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. 
  • Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery. 
  • Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients. 
  • Intimal tears and their relationship to long-term patency in the rat femoral artery. 
  • Invited commentary. 
  • Laser in infrapopliteal and popliteal stenosis 2 study (LIPS2): Long-term outcomes of laser-assisted balloon angioplasty versus balloon angioplasty for below knee peripheral arterial disease. 
  • Limb ischemia: cardiovascular diagnosis and management from head to toe. 
  • Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. 
  • Long-term results of endoscopic versus open saphenous vein harvest for lower extremity bypass. 
  • Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study. 
  • Maintenance of permanent hemodialysis vascular access patency. 
  • Management of infrainguinal occluded vein bypasses with a combined approach of thrombolysis and surveillance. A prospective study. 
  • Measurement of vascular input impedance in infrainguinal vein grafts. 
  • Micro-anastomosis of 0.3-0.4 mm vessels after cold ischemia using a rat model of toe-to-thumb transplantation. 
  • Microsurgical composite tissue transplantation at difficult recipient sites facilitated by preliminary installation of vein grafts as arteriovenous loops. 
  • Microvascular anastomoses in growing vessels: a long-term evaluation of nonabsorbable suture materials. 
  • Midterm follow-up after pharmacomechanical thrombolysis for lower extremity deep venous thrombosis. 
  • Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. 
  • Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. 
  • Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. 
  • Nitinol intravascular stent: results of preclinical evaluation. 
  • Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. 
  • Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction. 
  • Outcome after autogenous brachial-basilic upper arm transpositions in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era. 
  • Outcome of lower extremity revascularization for peripheral artery occlusive disease: is there a difference between men and women? 
  • Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. 
  • Outcomes of Femoropopliteal Bypass for Lifestyle-Limiting Claudication in the Endovascular Era. 
  • Outcomes of carotid-subclavian bypass performed in the setting of thoracic endovascular aortic repair. 
  • Outcomes of prosthetic hemodialysis grafts after deployment of bare metal versus covered stents at the venous anastomosis. 
  • Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy. 
  • Paradoxical embolus following percutaneous thrombectomy of hemodialysis reliable outflow graft. 
  • Patency after repair of forearm arterial injuries in animal models. 
  • Patency and blood flow in gas denucleated arterial prostheses. 
  • Patency of the posterior communicating artery following treatment with the Pipeline Embolization Device. 
  • Patient-derived endothelial progenitor cells improve vascular graft patency in a rodent model. 
  • Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. 
  • Percutaneous angioplasty and stenting of the superficial femoral artery. 
  • Percutaneous interventions on the hemodialysis reliable outflow vascular access device. 
  • Performance of an automated real-time ST-segment analysis program to detect coronary occlusion and reperfusion. 
  • Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial. 
  • Plasminogen acceleration of urokinase thrombolysis. 
  • Popliteal artery aneurysms: a 25-year surgical experience. 
  • Popliteal-to-distal bypass: identifying risk factors associated with limb loss and graft failure. 
  • Postintervention Patency Rates and Predictors of Patency after Percutaneous Interventions on Intragraft Stenoses within Failing Prosthetic Arteriovenous Grafts. 
  • Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study. 
  • Predictive value of access blood flow and stenosis in detection of graft failure. 
  • Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. 
  • Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial. 
  • Prevention of restenosis: medical treatment and procedures for iliac occlusive disease. 
  • Prevention of venous thrombosis in microvascular surgery by transmural release of heparin from a polyanhydride polymer. 
  • Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia. 
  • Prognostic role of transesophageal echocardiography in acute type A aortic dissection. 
  • Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. 
  • Quantitation of vascular outflow by measurement of impedance. 
  • Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts. 
  • Reconstruction of rat femoral veins with microvascular prostheses. 
  • Reduction in wound morbidity rates following endoscopic saphenous vein harvest. 
  • Regarding "Radial artery deviation and reimplantation inhibits venous juxta-anastomotic stenosis and increases primary patency of radial-cephalic fistulas for hemodialysis". 
  • Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial). 
  • Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. 
  • Renal segmental microvascular responses to ANG II in AT1A receptor null mice. 
  • Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent. 
  • Renovascular disease in children and adolescents. 
  • Resident versus attending surgeon graft patency and clinical outcomes in on- versus off-pump coronary artery bypass surgery. 
  • Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial". 
  • Restoring Venous Patency with the ClotTriever Following Deep Vein Thrombosis. 
  • Results of high dose intravenous urokinase for acute myocardial infarction. 
  • Retinal microvasculature and cardiovascular health in childhood. 
  • Reverse redistribution on exercise thallium scintigraphy: relationship to coronary patency and ventricular function after myocardial infarction. 
  • Ruminating on OAT: is the case closed? 
  • Safety and Effectiveness of Retrograde Arterial Access for Endovascular Treatment of Critical Limb Ischemia. 
  • Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies. 
  • Safety and efficacy of sonicated albumin microspheres in perfusion and vein graft patency assessments. 
  • Salvaging vascular access and treatment of severe limb edema: case reports on the novel use of the hemodialysis reliable outflow vascular access device. 
  • Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. 
  • Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery? 
  • Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. 
  • Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty. 
  • Side-to-side sutureless vascular anastomosis with magnets. 
  • Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group. 
  • Simultaneous restenosis of Taxus and Cypher drug-eluting stents. 
  • Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. 
  • Single versus multiple internal mammary artery grafting for coronary artery bypass: 15-year follow-up of a clinical practice trial. 
  • Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. 
  • Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society (HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland (VASBI). 
  • Spliced arm vein grafts are a durable conduit for lower extremity bypass. 
  • Stacked proximal aortic cuffs: an "off-the-shelf" solution for treating focal thoracic aortic pathology. 
  • Stent Placement Across the Renal Vein Inflow in Patients Undergoing Venous Reconstruction Preserves Renal Function and Renal Vein Patency: Experience in 93 Patients. 
  • Subclavian vein to right atrial appendage bypass without sternotomy to maintain arteriovenous access in patients with complete central vein occlusion, a new approach. 
  • Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. 
  • Surgeon judgment and utility of transit time flow probes in coronary artery bypass grafting surgery. 
  • Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction. 
  • TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis. 
  • The association between coronary graft patency and clinical status in patients with coronary artery disease. 
  • The effect of heparin after microsurgical repair in traumatically damaged arteries. 
  • The effect of location and configuration on forearm and upper arm hemodialysis arteriovenous grafts. 
  • The fibula-flexor hallucis longus osteomuscular flap. 
  • Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. 
  • Treatment of Arm Swelling in Hemodialysis Patients with Ipsilateral Arteriovenous Access and Central Vein Stenosis: Conversion to the Hemodialysis Reliable Outflow Graft versus Stent Deployment. 
  • Treatment of central venous in-stent restenosis with repeat stent deployment in hemodialysis patients. 
  • Treatment strategies for microvascular dysfunction following acute myocardial infarction. 
  • Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. 
  • Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. 
  • Use of aspirin associates with longer primary patency of hemodialysis grafts. 
  • Vascular Calcification Markers and Hemodialysis Vascular Access Complications. 
  • Vein graft anastomoses with magnets. 
  • Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Science & Society
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology